Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Efficacy Study of SPI-1005 for Prevention of Chemotherapy Induced Hearing Loss

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01451853
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:48.248201+00:00
Published At
2017-09-25T00:00:00+00:00
Record Updated At
2017-09-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lung Cancer", "Head and Neck Cancer", "Hearing Loss", "Ototoxicity", "Tinnitus", "Neuropathy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-09-25"
protocolSection.identificationModule.nctId
"NCT01451853"
protocolSection.identificationModule.officialTitle
"Safety and Efficacy Study of SPI-1005 for Prevention of Chemotherapy Induced Hearing Loss"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Lung Cancer (protocolSection.conditionsModule.conditions)
  • Head and Neck Cancer (protocolSection.conditionsModule.conditions)
  • Hearing Loss (protocolSection.conditionsModule.conditions)
  • Ototoxicity (protocolSection.conditionsModule.conditions)
  • Tinnitus (protocolSection.conditionsModule.conditions)
  • Neuropathy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.